Literature DB >> 9924326

Longer-term visual outcome of eyes with retinopathy of prematurity treated with cryotherapy or diode laser.

M O'Keefe1, J O'Reilly, B Lanigan.   

Abstract

AIMS: Visual outcome of 66 eyes in 37 patients who had undergone treatment with either cryotherapy or diode laser for threshold retinopathy of prematurity was assessed.
METHODS: 17 patients, representing 30 eyes treated with cryotherapy, were examined at between 56 and 98 months corrected age (median 68 months). 20 patients representing 36 eyes treated with diode laser, were examined at between 30 and 66 months corrected age (median 51 months). Structural outcome was categorised as: optimal--flat posterior pole; suboptimal--macular ectopia, optic nerve hypoplasia, retinal fold involving the macula, and retinal detachment involving the macula.
RESULTS: Optimal structural outcome was, in the absence of amblyopia, associated with optimal visual acuity (of 6/12 or better) in all cases, with most eyes achieving a visual acuity of 6/9 or 6/6. Suboptimal structural outcome was invariably associated with suboptimal visual acuity. Amblyopia was present in eight out of 20 cryotherapy treated eyes and in five out of 26 laser treated eyes with an optimal structural outcome. Refractive errors were significantly less in laser treated eyes as was the incidence of anisometropic amblyopia.
CONCLUSION: Eyes treated with either cryotherapy or diode laser for threshold retinopathy of prematurity with optimal structural outcome are associated with development of optimal visual acuity--that is, 6/12 or better. Treatment with either cryotherapy or laser does not in itself reduce the visual potential of these eyes.

Entities:  

Mesh:

Year:  1998        PMID: 9924326      PMCID: PMC1722408          DOI: 10.1136/bjo.82.11.1246

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study.

Authors:  F Laws; D Laws; D Clark
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

2.  Diode laser photocoagulation for retinopathy of prematurity. Preliminary results.

Authors:  J A McNamara; W Tasman; J F Vander; G C Brown
Journal:  Arch Ophthalmol       Date:  1992-12

3.  Diode laser for retinopathy of prematurity--early outcome.

Authors:  M Goggin; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

4.  Advanced cicatricial retinopathy of prematurity--outcome and complications.

Authors:  D M Knight-Nanan; K Algawi; R Bowell; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

5.  Refractive outcome in eyes with retinopathy of prematurity treated with cryotherapy or diode laser: 3 year follow up.

Authors:  D M Knight-Nanan; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

6.  Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome.

Authors:  J E White; M X Repka
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1997 Mar-Apr       Impact factor: 1.402

7.  Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity.

Authors:  A Capone; R Diaz-Rohena; P Sternberg; B Mandell; H M Lambert; P F Lopez
Journal:  Am J Ophthalmol       Date:  1993-10-15       Impact factor: 5.258

8.  Prediction of visual function in eyes with mild to moderate posterior pole residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors:  J Reynolds; V Dobson; G E Quinn; W S Gilbert; B Tung; J Robertson; J T Flynn
Journal:  Arch Ophthalmol       Date:  1993-08

9.  Diode laser treatment for retinopathy of prematurity: structural and functional outcome.

Authors:  C S Ling; B W Fleck; E Wright; C Anderson; I Laing
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

  9 in total
  7 in total

1.  Diode laser treatment of posterior retinopathy of prematurity.

Authors:  R Axer-Siegel; M Snir; D Cotlear; A Maayan; R Frilling; I Rosenbaltt; D Weinberger; I Kremer; L Sirota
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Retinopathy of prematurity screening by non-retinologists.

Authors:  Raj Vardhan Azad; Nonavinakere P Manjunatha; Nikhil Pal; Ashok K Deorari
Journal:  Indian J Pediatr       Date:  2006-06       Impact factor: 1.967

3.  Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

Authors:  David K Coats
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 4.  Long term functional and structural outcomes of laser therapy for retinopathy of prematurity.

Authors:  E McLoone; M O'Keefe; S McLoone; B Lanigan
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

Review 5.  [Current ophthalmic aspects of acute retinopathy of prematurity].

Authors:  B Lorenz
Journal:  Ophthalmologe       Date:  2008-12       Impact factor: 1.059

6.  Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions.

Authors:  Lara Carroll; Leah A Owen
Journal:  Explor Med       Date:  2020-02-29

7.  The Serine Protease HTRA-1 Is a Biomarker for ROP and Mediates Retinal Neovascularization.

Authors:  Leah A Owen; Kinsey Shirer; Samuel A Collazo; Kathryn Szczotka; Shawna Baker; Blair Wood; Lara Carroll; Benjamin Haaland; Takeshi Iwata; Lakshmi D Katikaneni; Margaret M DeAngelis
Journal:  Front Mol Neurosci       Date:  2020-11-17       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.